# Archimed

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/archimed

- Industry: Software
- Headquarters: Lille, France
- Website: www.archimed.fr/
- Total disclosed funding: $3.5M
- Latest round: Seed (Jan 13, 2026)
- Investors on record: 2

## About

Based in France, Archimed specializes in managing and disseminating cultural content and services through innovative technologies, primarily its Syracuse platform.Archimed is a cultural content management company headquartered in Lille, France. The company focuses on enhancing cultural policies and audience engagement through its technology solutions. Recently, Archimed raised EUR 3 million in Seed funding from investors Bpifrance and IRD Invest, marking a pivotal moment in expanding its offerings. The company has completed one deal as of January 13, 2026. The founder’s history is not detailed in available information.Archimed specializes in the management and dissemination of cultural content and services, primarily through its flagship product, the Syracuse platform. This innovative solution enhances cultural policies by addressing the challenges of engaging audiences with cultural venues. Syracuse provides a multi-service cultural portal that harmonizes digital strategies for user engagement, allowing institutions like municipal libraries, museums, and educational organizations to present their collections effectively. The platform also features Syracuse Genius, which leverages data intelligence for exploring rich metadata and documents while ensuring data security. Archimed's services are targeted at various geographical markets, including regions across Europe.Archimed's revenue model is based on subscriptions and partnerships with cultural institutions, including public libraries, museums, and educational entities. Clients engage with the Syracuse platform through tailored subscriptions that provide solutions for cultural content management. Revenue is generated through recurring transactions as institutions pay for access to the platform's features designed to enhance engagement. Archimed focuses on B2B relationships with cultural organizations and institutions.In February 2026, Archimed secured EUR 3 million in Seed funding to support the commercial expansion of its Alfeo SaaS knowledge management platform. The company aims to launch new product features and enhance its presence in European markets, specifically targeting institutions that prioritize digital transformation and cultural accessibility. The recent funding will facilitate these initiatives, supporting strategic growth and operational enhancements.

## Funding rounds

- Seed, Jan 13, 2026, $3.5M — Bpifrance Investissement, IRD Invest

## Investors

- Bpifrance Investissement (https://capitalatlas.ai/funds/bpifrance-investissement) — Seed
- IRD Invest (https://capitalatlas.ai/funds/ird-invest) — Seed